NCT00043680
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
- Locations
-
- National Eye Institute (NEI) Bethesda, Maryland, United States
Clinical trial condition
Neovascularization, Pathologic
Explore clinical trials studying Neovascularization, Pathologic. Study availability and eligibility vary by location and protocol.
204 public trials
15 recruiting studies
Neovascularization, Pathologic trial results
NCT00417703
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +5 more
- Locations
-
- Retina Support Services, Inc Tulsa, Oklahoma, United States
NCT00555113
- Conditions
- Angioid Streaks, Cardiovascular Diseases, Choroid Diseases, +22 more
- Locations
-
- Department of ophthalmology, HEGP Paris, France
Completed
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
NCT00426998
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
- Locations
-
- Retinal Consultants Medical Group, Inc. Sacramento, California, United States
Completed
Myopic Macular Haemorrhages
NCT00345228
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
- Locations
-
- Singapore National Eye Centre Singapore
NCT00135837
- Conditions
- Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
- Locations
-
- Novartis Basel, Switzerland
NCT00305630
- Conditions
- Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
- Locations
-
- Johns Hopkins Univeristy School of Medicine Baltimore, Maryland, United States
- Oregon Health Science Univeristy Portland, Oregon, United States
NCT00000153
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +14 more
- Locations
-
Not specified
NCT00021736
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
- Locations
-
- Foundation for Fighting Blindness Baltimore, Maryland, United States
Active, Not Recruiting
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
NCT04704921
- Conditions
- AMD, CNV, Choroid Diseases, +18 more
- Locations
-
- Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
- Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
- University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
- Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States